Cogan's syndrome: Unsuccessful outcome with early combination therapy

Clinical and Experimental Rheumatology

Volumn 17, Issue 4, 1999, Pages 479-483

  Covelli, M ^a   Lapadula, G ^a   Pipitone, V ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Cogan's syndrome; Cyclophosphamide; Cyclosporin; Glucocorticoids; Nervous system involvement

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; GAMMA INTERFERON; GLUCOCORTICOID; INTERLEUKIN 2; INTERLEUKIN 3; MEPREDNISONE; PREDNISONE;

ADULT; ARTICLE; CASE REPORT; COGAN SYNDROME; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG EFFICACY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEVER; FOLLOW UP; HEARING LOSS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY DISEASE; LONG TERM CARE; LOW BACK PAIN; MYALGIA; ORAL DRUG ADMINISTRATION; PHOTOPHOBIA; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; VERTIGO;

ADULT; ANTI-INFLAMMATORY AGENTS; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; HEARING LOSS, SENSORINEURAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KERATITIS; METHYLPREDNISOLONE; TREATMENT FAILURE; VASCULITIS;

EID: 0032817324     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. FIDLER H, JONES NS: Late onset Cogan's syndrome. J Laryngol Otol 1989; 103:512-4.
2. ELKAYAM O, CASPI D, GEYER O, YARON M: Atypical Cogan's syndrome in a 76-year-old woman. J Rheumatol 1992; 19: 1324-5.
3. COGAN DG: Syndrome of non-syphilitic interstitial keratitis and vestibulo-auditory symptoms. Arch Ophthalmol 1945; 33: 144-9.
4. OLINER L, TAUBENHAUS M, SHAPIRO TM, LESHIN N: Non-syphilitic interstitial keratitis and bilateral deafness (Cogan's syndrome) associated with essential polyangiitis (periarteritis nodosa). N Engl J Med 1953; 248: 1001-8.
5. CRAWFORD WJ: Cogan's syndrome associated with polyarteritis nodosa. Pennsylvania Med J 1957; 60: 835-8.
6. EISENSTEIN B, TAUBENHAUS M: Non-syphilitic interstitial keratitis and bilateral deafness (Cogan's syndrome) associated with cardiovascular disease. N Engl J Med 1958; 258: 1074-9.
7. FISHER ER, HELLSTROM HR: Cogan's syndrome and systemic vascular disease: Analysis of pathologic features with reference to its relationship to thromboangiitis obliterans (Buerger). Arch Pathol 1961; 72: 572-92.
8. CHESON BD, BLUMING AZ, ALROY J: Cogan's syndrome; A systemic vasculitis. Am J Med 1976; 60: 549-55.
9. BASTUG DE, DOMINIC A, ORTIZ O, DIBARTOLOMEO AG, KOTZAN JM, ABRAHAM FM: Popliteal artery thrombosis in a patient with Cogan syndrome: Treatment with thrombolysis and percutaneous transluminal angioplasty. Cardiovasc Intervent Radiol 1997; 20: 57-9.
10. HAYNES BF, KAISER-KUPFER MI, MASON P, FAUCI AS: Cogan's syndrome: Studies in thirteen patients, long-term follow-up, and a review of the literature. Medicine 1980; 59: 426-41.
11. VOLLERTSEN RS, MCDONALD TJ, YOUNGE BR, BANKS PM, STANSON AW, ILSTRUP DM: Cogan's syndrome: 18 cases and a review of the literature. Mayo Clin Proc 1986; 61: 344-61.
12. WILDER-SMITH E, ROELCKE U: Cogan's syndrome. J Clin Neuro-Ophthalmol 1990; 10: 261-3.
13. VOLLERSTEN RS: Vasculitis and Cogan's syndrome. Rheum Dis Clin North Am 1990; 16: 433-9.
14. COCHRANE AD, TATOULIS J: Cogan's syndrome with aortitis, aortic regurgitation, and aortic vessel stenosis. Ann Thoracic Surg 1991; 52: 1166-7.
15. LIVINGSTON JZ, CASALE AS, HUTCHINS GM, SHAPIRO EP: Coronary involvement in Cogan's syndrome. Am Heart J 1992; 123: 528-30.
16. HAMMER M, WITTE T, MÜGGE A et al.: Complicated Cogan's syndrome with aortic insufficiency and coronary stenosis. J Rheumatol 1994; 21: 552-5.
17. COGAN DG: Non-syphilitic interstitial keratitis with vestibuloauditory symptoms: Report of 4 additional cases. Arch Opthalmol 1949; 42: 42-9.
18. HAYNES BF, PIKUS A, KRISER-KUPFER MI, FAUCI AS: Successful treatment of sudden hearing loss in Cogan's syndrome with corticosteroids. Arthritis Rheum 1981; 24: 501-3.
19. BACHINSKI B, WISE J: Cogan's syndrome: A treatable cause of neurosensory deafness. Can J Ophthalmol 1984; 19: 145-7.
20. ALLEN NB, COX CC, COBO M et al: Use of immunosuppressive agents in the treatment of severe ocular and vascular manifestations of Cogan's syndrome. Am J Med 1990; 88: 296-301.
21. SHAH P, LUQMANI RA, MURRAY PI, HONAN WP, CORRIDAN PGJ, EMERY P: Posterior scleritis - An unusual manifestation of Cogan's syndrome. Br J Rheumatol 1994; 33: 774-5.
22. RICHARDSON B: Methotrexate therapy for hearing loss in Cogan's syndrome. Arthritis Rheum 1994; 37: 1559-61.
23. RAZA K, KAROKIS D, KITAS GD: Cogan's syndrome with Takayasu's arteritis. Br J Rheumatol 1998; 37: 369-72.
24. BICKNELL JM, HOLLAND JV: Neurologic manifestations of Cogan's syndrome. Neurology 1978; 28: 278-81.
25. FERRARI E, TAILLAN B, GARNIER G, DOR V, MORAND P, DUJARDIN P: Manifestations cardiovasculaires des syndrome de Cogan. Arch Mal Coeur 1992; 85: 913-6.
26. SIGAL LH: The neurologic presentation of vasculitic and rheumatologic syndromes. Medicine 1987; 66: 157-80.
27. MANTO MU, JACQUY J: Cerebellar ataxia in Cogan's syndrome. J Neurol Sci 1996; 136: 189-91.
28. SIMONCELLI C, RICCI G, MOLINI E, SILVESTRI L, GIOMMETTI S: Résultats des examens audiométriques et vestibulaires dans le syndrome de Cogan: A propos d'un cas. Rev de Laringologie 1992; 113: 121-4.
29. MERLE H, TRODE M, SMADJA D, NUMERIC P, RICHER R, JALLOT-SAINTE-ROSE N: Kératite interstitielle et syndrome de Cogan. J Fr Ophtalmol 1995; 18: 50-4.
30. CHYNN EN, JAKOBIEC FA: Cogan's syndrome: Ophthalmic, audiovestibular, and systemic manifestations and therapy. Int Ophthalmol Clin 1996; 36: 61-72.
31. KANTOR TG: Corticosteroids in Cogan's syndrome (letter) Arthritis Rheum 1981; 24: 1588.
32. POUCHOT J, VINCENEUX P, BOUCCARA D, STERKERS O, BODELET B: Methotrexate as a steroid-sparing agent in Cogan's syndrome: Comment on the concise communication by Richardson. Arthritis Rheum 1995; 38: 1348-9.
33. RIENTE L, TAGLIONE E, BERRETTINI S: Efficacy of methotrexate in Cogan's syndrome (letter). J Rheumatol 1996; 23: 1830-1.
34. VAIOPOULOS G, SFIKAKIS PP, SKOUMAS B, KAVOUKUS E, DOUKAS E, KAKLAMANIS PH: Lack of response to corticosteroids and pulse cyclophosphamide therapy in Cogan's syndrome Clin Rheumatol 1994; 13: 110-2.
35. LHOTE F, COHEN P, GUILLEVIN L: Polyarteritis nodosa, microscopic polyangiitis and Churg-Strauss syndrome Lupus 1998; 7: 238-58.
36. DE-GROOT K, GROSS WL: Wegener's granulomatosis: Disease course, assessment of activity and extent and treatment. Lupus 1998; 7: 285-91.
37. FAUCI AS, WOLFF S: Wegener's granulomatosis: Studies in eighteen patients and a review of the literature. Medicine (Baltimore) 1973; 52: 535-61.
38. FAUCI AS, HAYNES BF, KATZ P, WOLFF SM: Wegener's granulomatosis: Prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983; 98: 76-85.
39. HOFFMAN GS, KERR GS, LEAVITT RV et al.: Wegener's granulomatosis: An analysis of 158 patients. Ann Intern Med 1992; 116: 448-94.
40. CAMERON JS: The treatment of severe vasculitis: General principles and the use of corticosteroids. Rheumatology in Europe 1994; 23 (Suppl 2.): 25-6.
41. LE THI HUONG D, PAPO T, PIETTE JC et al.: Monthly intravenous pulse cyclophosphamide therapy in Wegener's granulomatosis. Clin Exp Rheumatol 1996; 14: 9-16.
42. HAGA HJ, D'CRUZ D, ASHERSON R, HUGHES G: Short term effects of intravenous pulses of cyclophosphamide in the treatment of connective tissue disease crisis. Ann Rheum Dis 1992; 51: 885-8.
43. GUILLEVIN L, CORDIER J-F, LHOTE F et al.: A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis. Arthritis Rheum 1997; 40: 2187-98.
44. HOFFMAN GS: Treatment of Wegener's granulomatosis: Time to change the standard of case? Arthritis Rheum 1997; 40: 2099-104.
45. WESTMAN KW, BYGREN PG, OLSSON H, RANSTAM J, WIESLANDER J: Relapse rate, renal survival, and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement. J Am Soc Nephrol 1998; 9: 842-52.
46. LANGFORD CA: Use of cytotoxic agents and cyclospoiine in the treatment of autoimmune disease. Ann Intern Med 1998; 129: 49-58.
47. CALABRESE LH: Therapy of systemic vasculitis. Neurol Clin 1997; 15: 973-91.
48. MCDERMOTT AM, POWELL RJ: Cyclosporin in the treatment of Churg-Strauss syndrome. Ann Rheum Dis 1998; 57: 258-9.
49. SCHMALDIENST S, WINKLER S, BREITENEDER S, HÖRL WH: Severe nephrosis syndrome in a patient with Schönlein-Henoch purpura: A complete remission after cyclosporin A. Nephrol Dial Transplant 1997; 12: 790-2.
50. SÜLLÜY, ÖGE I, ERKAN D, ANTÜRK N, MOHAJERI F: Cyclosporin A therapy in severe uveitis of Behçet disease. Acta Ophthalmol Scand 1998; 76: 96-9.
51. GROSS NL: New developments in the treatment of systemic vasculitis. Curr Opin Rheumatol 1994; 6: 11-9.
52. PANAYI GS, TUGWELL P: The use of cyclosporin A in rheumatoid arthritis: Conclusions of an international review. Br J Rheumatol 1994; 33: 967-9.
53. NARVAEZ J, VALVERDE GARCIA J, ALEGRE SANCHO JJ, JUANOLA X, CLAVAGUERA MT, ROIG ESCOFET D: Sudden cochlear hearing loss in a patient with Behçet's disease. Rev Rhum (Engl. ed.) 1998; 65: 63-4.
54. MINET M, DEGGOUJ N, GERSDORFF M: Cochlear implantation in patients with Cogan's syndrome: A review of four cases. Eur Arch Otorhinolaryngol 1997; 254: 459-62.
55. CINAMON U, KRONENBERG J, HILDESHEIMER M, TAITELBAUM R: Cochlear implantation in patients suffering from Cogan's syndrome J Laryngol Otol 1997; 111: 928-30.